Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
NCT03226444
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
204
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Sjögren Syndrome
Dry Eye
Interventions
DRUG:
0.005% Lacripep
DRUG:
0.01% Lacripep
DRUG:
Placebo
Sponsor
TearSolutions, Inc.